Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity

被引:155
作者
Breivogel, CS
Selley, DE
Childers, SR
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Ctr Neurobiol Invest Drug Abuse, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Ctr Investigat Neurosci, Winston Salem, NC 27157 USA
关键词
D O I
10.1074/jbc.273.27.16865
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The relationship between GDP and cannabinoid-stimulated [S-35]guanosine-5'-O-(3-thiotriphosphate) ([S-35]GTP gamma S) binding was investigated in rat cerebellar membranes. Kinetic analyses showed that [35S]GTP gamma S binding reached steady-state levels and that the association rate was increased by the agonist WIN 55212-2 proportional to the concentration of GDP. Dissociation of [S-35]GTP gamma S occurred with two rates (t(1/2) = 7 and 170 min), and WIN 55212-2 increased the proportion of sites exhibiting the faster rate. Without GDP, [S-35]GTP gamma S bound to membranes with high and low affinity, and WIN 55212-2 had no effect. With 30 mu M GDP, [S-35]GTP gamma S bound to low and intermediate affinity sites, and WIN 55212-2 induced high affinity [S-35]GTP gamma S binding without affecting low affinity sites, GDP competed for high affinity [S-35]GTP gamma S binding with high and intermediate affinity in the absence of WIN 55212-2 and with high and low affinity in the presence of WIN 55212-2. Cannabinoid ligands displayed differential abilities to maximally stimulate [S-35]GTP gamma S binding in the presence of GDP. Efficacy differences among ligands increased with increasing GDP concentrations. GDP competition curves revealed that agonists induced low affinity GDP Ki values that were proportional to agonist E-max values, indicating that agonist efficacy is determined by displacement of GDP from G-proteins.
引用
收藏
页码:16865 / 16873
页数:9
相关论文
共 55 条
  • [1] [Anonymous], PHARM ANAL DRUG RECE
  • [2] CATECHOLAMINE-STIMULATED GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE) BINDING TO THE STIMULATORY GTP-BINDING PROTEIN OF ADENYLATE-CYCLASE - KINETIC-ANALYSIS IN RECONSTITUTED PHOSPHOLIPID-VESICLES
    ASANO, T
    ROSS, EM
    [J]. BIOCHEMISTRY, 1984, 23 (23) : 5467 - 5471
  • [3] CANNABINOID RECEPTORS AND MODULATION OF CYCLIC-AMP ACCUMULATION IN THE RAT-BRAIN
    BIDAUTRUSSELL, M
    DEVANE, WA
    HOWLETT, AC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 55 (01) : 21 - 26
  • [4] RECEPTOR-TO-EFFECTOR SIGNALING THROUGH G-PROTEINS - ROLES FOR BETA-GAMMA-DIMERS AS WELL AS ALPHA-SUBUNITS
    BIRNBAUMER, L
    [J]. CELL, 1992, 71 (07) : 1069 - 1072
  • [5] BOKOCH GM, 1984, J BIOL CHEM, V259, P3560
  • [6] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
    Bouaboula, M
    Perrachon, S
    Milligan, L
    Canat, X
    RinaldiCarmona, M
    Portier, M
    Barth, F
    Calandra, B
    Pecceu, F
    Lupker, J
    Maffrand, JP
    LeFur, G
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
  • [7] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [8] Breivogel CS, 1997, J NEUROCHEM, V68, P1462
  • [9] Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632
  • [10] Delta(9)-tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain
    Burkey, TH
    Quock, RM
    Consroe, P
    Roeske, WR
    Yamamura, HI
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) : R3 - R4